A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions
Clinical trial NCT04914598 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04914598
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2025-02-10
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.